Zhejiang Starry Pharmaceutical Co (SHSE:603520) Net Change in Cash : ¥-145 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Zhejiang Starry Pharmaceutical Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Zhejiang Starry Pharmaceutical Co's Net Change in Cash for the three months ended in Mar. 2025 was ¥-117 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-145 Mil.

Zhejiang Starry Pharmaceutical Co Net Change in Cash Historical Data

The historical data trend for Zhejiang Starry Pharmaceutical Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Starry Pharmaceutical Co Net Change in Cash Chart

Zhejiang Starry Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

394.98

-74.99

-35.50

-125.61

-18.91

Zhejiang Starry Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															9.21	607.10	-581.33	-53.89	-117.21

Zhejiang Starry Pharmaceutical Co Net Change in Cash Calculation

Zhejiang Starry Pharmaceutical Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	193.502	+	-490.735	+	299.029	+	-20.702
	=	-19

Zhejiang Starry Pharmaceutical Co's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 74.292 + -77.904 + -113.985 + 0.388

= -117

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-145 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Starry Pharmaceutical Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Zhejiang Starry Pharmaceutical Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Starry Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Starry Pharmaceutical Co Ltd (SHSE:603520) » Definitions » Net Change in Cash

Comparable Companies

SHSE:600530 SZSE:300111 SZSE:002082 SZSE:002693 SHSE:688073 SZSE:301509 SZSE:002900 SZSE:300110 SHSE:688117 SZSE:002365 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA

Traded in Other Exchanges

N/A

Address

No.1 Sitali Avenue, Modern Industrial Gathering District, Zhejiang Province, Xianju County, Taizhou City, CHN, 317306

Website

http://www.starrypharm.com

Zhejiang Starry Pharmaceutical Co Ltd is engaged in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.

Executives

Hu Jin Sheng Director

Zhejiang Starry Pharmaceutical Co Headlines

No Headlines